The integral membrane protein encoded by this gene is a lysophosphatidic acid (LPA) receptor from a group known as EDG receptors. These receptors are members of the G protein-coupled receptor superfamily. Utilized by LPA for cell signaling, EDG receptors mediate diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, chemotaxis, and tumor cell invasion. Alternative splicing of this gene has been observed and two transcript variants have been described, each encoding identical proteins. An alternate translation start codon has been identified, which results in isoforms differing in the N-terminal extracellular tail. In addition, an alternate polyadenylation site has been reported.
^An S, Dickens MA, Bleu T, Hallmark OG, Goetzl EJ (February 1997). “Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid”. Biochem. Biophys. Res. Commun. 231 (3): 619–22. doi:10.1006/bbrc.1997.6150. PMID9070858.
An S, Goetzl EJ, Lee H (1999). “Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate”. J. Cell. Biochem. Suppl. 30-31: 147–57. PMID9893266.
Contos JJ, Ishii I, Chun J (2001). “Lysophosphatidic acid receptors”. Mol. Pharmacol. 58 (6): 1188–96. PMID11093753.
An S, Bleu T, Zheng Y, Goetzl EJ (1998). “Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization”. Mol. Pharmacol. 54 (5): 881–8. PMID9804623.
Cervera P, Tirard M, Barron S, et al. (2002). “Immunohistological localization of the myelinating cell-specific receptor LP(A1)”. Glia. 38 (2): 126–36. doi:10.1002/glia.10054. PMID11948806.
Hama K, Bandoh K, Kakehi Y, et al. (2002). “Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors”. FEBS Lett. 523 (1–3): 187–92. doi:10.1016/S0014-5793(02)02976-9. PMID12123830.
Van Leeuwen FN, Olivo C, Grivell S, et al. (2003). “Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1”. J. Biol. Chem. 278 (1): 400–6. doi:10.1074/jbc.M210151200. PMID12393875.
Murph MM, Scaccia LA, Volpicelli LA, Radhakrishna H (2004). “Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway”. J. Cell Sci. 116 (Pt 10): 1969–80. doi:10.1242/jcs.00397. PMID12668728.
Shida D, Kitayama J, Yamaguchi H, et al. (2003). “Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1”. Cancer Res. 63 (7): 1706–11. PMID12670925.
Matsuda A, Suzuki Y, Honda G, et al. (2003). “Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways”. Oncogene. 22 (21): 3307–18. doi:10.1038/sj.onc.1206406. PMID12761501.
Komuro Y, Watanabe T, Kitayama J, et al. (2004). “The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas”. Hepatogastroenterology. 50 (54): 1770–3. PMID14696401.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.
Kaneider NC, Lindner J, Feistritzer C, et al. (2005). “The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor”. FASEB J. 18 (11): 1309–11. doi:10.1096/fj.03-1050fje. PMID15208267.